Bringing genetic and biomarker context to your provider allows for a more personalized discussion about dose titration, expected adaptation timelines, and symptom management strategies tailored to your metabolic profile
doi:10.1016/j.arcmed.2005.01.003 30
Sockalingam S, Leung SE, Hawa R, Wnuk S, Parikh SV, Jackson T, et al
Administration: Oral Tablet
Owen: Early adopters have been instrumental in helping us refine the system
Resources We Trust Cleveland Clinic: This Is How to Lose Weight the Right Way and Keep It Off Johns Hopkins Medicine: Maintaining Weight Loss Massachusetts General Hospital: Fitness for People Taking GLP-1 Agonists: A Comprehensive Guide WashU Medicine: Stopping GLP-1 Drugs Can Quickly Erase Cardiovascular Benefits Yale School of Medicine: What Is the Impact of GLP-1s in Older Adults With Obesity